Select | Gene | Cds | Cds_length | GC_content | Pep | Pep_length |
---|---|---|---|---|---|---|
Pral2022g00005 | ATGAAGGATCTCAAAAAGAATTCCCGCTTTGAGTCATTTTCCCTGCCGACCCCACCTCCTAATCTCAATGATCAATTTTCTTCCAAGGATGTCATGGATTTCAAATCAAGGGAGTCGATTTTTAATAGCCTTTTTGAGGCTATTAAAGATGGCAAGAACAAGATGGTGGGCCTGTATGGTATGGGGGGCTCAGGTAAAACCACCTTGGCAATCGAAGTGGGTAAGAAAGTTGAACGGCTGAAGCTTTTTGACAAAGTGGTCAAGGTGGTTGTCTCTCGGCCTCTTAATGTTGGGAAAATCCAAGAAGAAATAAAAGGAAAAACAGGTTTGAAATTTGAGGAAGATATCGAATCAACCGCAGCAAGGCTATTAACTGAATTGAAAAGTATGAAAATACTTATAATCTTGGACGATGTTTGGAGCAATCTAAATCTCCAAGAAATTGGTATACCGATTAATGAAAATTGTCGTGTTTTGTTAACTACCCGTCGTCGACATGTTTGTGTCTCTATGGGTTGCGAGAAAAAATTTGAATTGTCTCTCTTAATAGAGGAGGAAGCATGGGATTTGTTAAAGATGCATGCAAACATAACCCATGACTCATTGAATGAGTTTGATGGTGTGGGAAAGAAAATTGTTGATAAGTGCAAGGGACTACCTATTGCAATTGTGACAATGGGAAGGGCATTAAGAGGAAAAGGAATTGTGGAGTGGAAGTCAGCACTATGGAGGCTACAACAAGCCCTACCATTGGATATTGATGATGAGAGTTCAAGGGACCCTTATGCATGTCTCAAATTGAGTTATGATTATTTGCCAACAAGTCTAGCAAAGCAACTCTTCCTATTGTGCTCTATGTTTCCTGAGGATCATCAAATTCATAGAGAGGATCTTATTCGATTTGCTAAAGGGACTTTGAAATTTGAGGGGAATATTGTTTACGCAGTGGAGGATGCAAGGAGGGAGATTTTAGTGAGCATCAATAGTCTATTAGATTCTTGTTTATTAATGCATACGAATGAGCCAGCACGTGTAAAAATGCATGACTTAGTTCGGGATGTAGCTTTATGGATTGCAAGGGAGCAACATCAAGCAATTTTGGTGGATAGCGATGCGGTTTTTAAAATGTTGGCTGAAAATGGAAGTTTGAAAGAGACAAAGGTAATATCATTATGGAATCTGAGAGGCAATTTTCTGCAGTCTAATCAATTGCATTGTCCAACACTTGAGGTTCTGCTACTTCATCCCGAAGGGTTCATTGAAGATCTTGGAGGGATTGAAGCGCTCAAAATCTTGGGCCTTGTAATATCTAGCTTTCAATGGGGACGACTTGGTTGGAAGAGGTCACCTTTTCAGCTAATGCAGAATCAATGGTCAATGCTGCAATCAATTGTGTCATCATTAATTAATCTTCATACCTTATGCATCAGAGGAATTGCATTGGGTGACATCTCTTTTCTAGGTCAACTCAAAGGATTAGAGATTCTTGACTTGCGTGGTTCTCAATTTGATGAATTACCTATTAGAATTGTAGATATGAAAAAATTGAAGCTGTTGGATGTGTTTAGGTGTGAAATTGAGAGAAGTCCTTTAGAAGTTATTGGAAGATGTGAGCAACTTGAGGAATTATACTTTTGGAATAAGAAATTTGTCATCCCAGAAAATTTCTCTCTTTCAAGGTTGAAGAGGTACGTTATCTATGACACCACATCATTGAATATTTCTAGTTATGAAGATCCTCCTCTTGTAGAATATTTTGATGCTCATTGCATTGAAGAACTGAGAGCTTTATGCATACAAGGCTTCAAAGCCTCTGTTTCGAATTCGTCAATGAAAGATCTTATTCTTGGAGCAAACTGCCTTTGGCTAGAGAATTGTAGATGGGATCTTAATGATATAAATTCTGAAATAAAGCACTTAGCAATTTCATGCTGTGTGGAGAAGAGATTCATAGCTGATAGCCTGAGCACCAACAATCTTCAAACAGGACAAGTGTTCTCCCACCTGATTAGTTTAAGATTGAGACAAATGAATAGTCTTGATCGAGTGTTCCAAGATTCATCGATCACATGTTCTCTCCCGATGTTACAAGAGCTGTTTCTAGAGAGGTGTCCAGAATTGGGAACCAGCATCTTCACCCATGCCACTGTTACAAGCCTACCGAAGCTGAGGAAACTTGAGATTGAGGATTGCAGCAAATTGAAATGGCTATTCTCTTATTCTCTGGCTTCTCAGTGTCCTTCGCTAGAGGAATTGCAAATACAGTATTGTTATAAACTTGAGAGGCTCACTGATGAAGAAGATGTGCATGGTGATTGTCTACCGCACCAAAGGGAGCCCCTTCAAGACTACCCATACGGGAATCCGACTGTGGTCACTACTGTAGAAAGCTCCCACCATTCACGCAATCCAAGGAAAAAAAACCGGACTGGACCAGCCGGTTCAACCGAAAAACCGGTGAACCGGTCTGCAGTCCGGTCTGGTTTAATTGGTAAACCGGTAATCAATCAAACCGGTGAAAAACCGGTTCAACCGGTGGTAACCGGTATAGAACCGGGTTATCCCGGTTGGCTGGGTTACCGGTTCTTCTTTAGCGTGAATGAACGAGTTCGACCCACCAACGACGATGGGAATCTCCCTCCTGGAAGTAATGTCGGAGATGACAGAGCCAAGGCGCAAGCAAAAATCTAA | 2691 | 0.4073 | MKDLKKNSRFESFSLPTPPPNLNDQFSSKDVMDFKSRESIFNSLFEAIKDGKNKMVGLYGMGGSGKTTLAIEVGKKVERLKLFDKVVKVVVSRPLNVGKIQEEIKGKTGLKFEEDIESTAARLLTELKSMKILIILDDVWSNLNLQEIGIPINENCRVLLTTRRRHVCVSMGCEKKFELSLLIEEEAWDLLKMHANITHDSLNEFDGVGKKIVDKCKGLPIAIVTMGRALRGKGIVEWKSALWRLQQALPLDIDDESSRDPYACLKLSYDYLPTSLAKQLFLLCSMFPEDHQIHREDLIRFAKGTLKFEGNIVYAVEDARREILVSINSLLDSCLLMHTNEPARVKMHDLVRDVALWIAREQHQAILVDSDAVFKMLAENGSLKETKVISLWNLRGNFLQSNQLHCPTLEVLLLHPEGFIEDLGGIEALKILGLVISSFQWGRLGWKRSPFQLMQNQWSMLQSIVSSLINLHTLCIRGIALGDISFLGQLKGLEILDLRGSQFDELPIRIVDMKKLKLLDVFRCEIERSPLEVIGRCEQLEELYFWNKKFVIPENFSLSRLKRYVIYDTTSLNISSYEDPPLVEYFDAHCIEELRALCIQGFKASVSNSSMKDLILGANCLWLENCRWDLNDINSEIKHLAISCCVEKRFIADSLSTNNLQTGQVFSHLISLRLRQMNSLDRVFQDSSITCSLPMLQELFLERCPELGTSIFTHATVTSLPKLRKLEIEDCSKLKWLFSYSLASQCPSLEELQIQYCYKLERLTDEEDVHGDCLPHQREPLQDYPYGNPTVVTTVESSHHSRNPRKKNRTGPAGSTEKPVNRSAVRSGLIGKPVINQTGEKPVQPVVTGIEPGYPGWLGYRFFFSVNERVRPTNDDGNLPPGSNVGDDRAKAQAKI | 896 |
Select | Seq ID | Length | Analysis | Description | Start | End | IPR | GO |
---|---|---|---|---|---|---|---|---|
Pral2022g00005 | 896 | SMART | AAA_5 | 52 | 194 | IPR003593 | GO:0016887 | |
Pral2022g00005 | 896 | MobiDBLite | consensus disorder prediction | 873 | 896 | - | - | |
Pral2022g00005 | 896 | PRINTS | Disease resistance protein signature | 126 | 140 | - | - | |
Pral2022g00005 | 896 | PRINTS | Disease resistance protein signature | 55 | 70 | - | - | |
Pral2022g00005 | 896 | PRINTS | Disease resistance protein signature | 718 | 734 | - | - | |
Pral2022g00005 | 896 | PRINTS | Disease resistance protein signature | 216 | 230 | - | - | |
Pral2022g00005 | 896 | Gene3D | - | 269 | 356 | IPR036388 | - | |
Pral2022g00005 | 896 | Gene3D | - | 182 | 268 | IPR042197 | - | |
Pral2022g00005 | 896 | MobiDBLite | consensus disorder prediction | 775 | 836 | - | - | |
Pral2022g00005 | 896 | FunFam | Probable disease resistance protein At1g61300 | 22 | 176 | - | - | |
Pral2022g00005 | 896 | Gene3D | Ribonuclease Inhibitor | 449 | 588 | IPR032675 | - | |
Pral2022g00005 | 896 | SUPERFAMILY | L domain-like | 346 | 764 | - | - | |
Pral2022g00005 | 896 | Gene3D | Ribonuclease Inhibitor | 592 | 769 | IPR032675 | - | |
Pral2022g00005 | 896 | Gene3D | - | 22 | 178 | IPR027417 | - | |
Pral2022g00005 | 896 | PANTHER | NB-ARC DOMAIN-CONTAINING PROTEIN-RELATED | 4 | 773 | - | - | |
Pral2022g00005 | 896 | Pfam | NB-ARC domain | 38 | 270 | IPR002182 | GO:0043531 | |
Pral2022g00005 | 896 | MobiDBLite | consensus disorder prediction | 1 | 25 | - | - | |
Pral2022g00005 | 896 | SUPERFAMILY | P-loop containing nucleoside triphosphate hydrolases | 20 | 284 | IPR027417 | - | |
Pral2022g00005 | 896 | MobiDBLite | consensus disorder prediction | 808 | 822 | - | - | |
Pral2022g00005 | 896 | MobiDBLite | consensus disorder prediction | 10 | 25 | - | - |
Select | Gene | Chromosome | Start | End | Duplicated_type |
---|---|---|---|---|---|
Pral2022g00005 | Pral-Chr2022 | 46015 | 49859 | Dispersed/Wgd |
Select | Gene | Gene_start | Gene_end | Function | Ath_gene | Identity(%) | E-value | Score |
---|---|---|---|---|---|---|---|---|
Pral2022g00005 | 54 | 365 | WRKY Transcription Factor Family | AT5G45050 | 24.383 | 5.20e-08 | 55.1 |
Select | Query | KO | Definition | Second KO | KEGG Genes ID | GHOSTX Score |
---|---|---|---|---|---|---|
Pral2022g00005 | - | - | pcin:129306241 | 883.634 |